Sofinnova Investments as of Dec. 31, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 59 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 11.1 | $154M | 1.1M | 139.12 | |
| Nextcure (NXTC) | 10.8 | $151M | 2.7M | 56.33 | |
| Karuna Therapeutics Ord | 10.2 | $142M | 1.9M | 75.34 | |
| Amarin Corporation | 8.1 | $112M | 5.2M | 21.44 | |
| Natera (NTRA) | 7.5 | $105M | 3.1M | 33.69 | |
| Principia Biopharma | 5.6 | $78M | 1.4M | 54.78 | |
| Y Mabs Therapeutics | 4.9 | $69M | 2.2M | 31.25 | |
| Galera Therapeutics (GRTX) | 2.9 | $41M | 3.1M | 13.16 | |
| BioMarin Pharmaceutical (BMRN) | 2.7 | $37M | 442k | 84.55 | |
| Coherus Biosciences (CHRS) | 2.5 | $35M | 1.9M | 18.01 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.2 | $31M | 139k | 218.95 | |
| Merus N V (MRUS) | 2.0 | $28M | 2.0M | 14.08 | |
| Ptc Therapeutics I (PTCT) | 1.8 | $25M | 517k | 48.03 | |
| Merck & Co (MRK) | 1.6 | $22M | 241k | 90.94 | |
| Regeneron Pharmaceuticals (REGN) | 1.4 | $19M | 50k | 375.46 | |
| Biogen Idec (BIIB) | 1.4 | $19M | 64k | 296.71 | |
| Obseva Sa | 1.3 | $18M | 4.7M | 3.82 | |
| United Therapeutics Corporation (UTHR) | 1.2 | $17M | 189k | 88.09 | |
| Chemocentryx | 1.1 | $15M | 377k | 39.55 | |
| Nucana Biomed ordinary shares | 1.1 | $15M | 2.4M | 6.10 | |
| Myokardia | 1.0 | $14M | 196k | 72.88 | |
| Mirati Therapeutics | 1.0 | $14M | 108k | 128.85 | |
| Nucana Plc american depositary shares | 1.0 | $14M | 2.3M | 6.10 | |
| Macrogenics (MGNX) | 0.9 | $13M | 1.2M | 10.88 | |
| Fate Therapeutics (FATE) | 0.9 | $12M | 635k | 19.57 | |
| ALNYLAM PHARMACEUTICALS INC. Common Stock cmn | 0.8 | $12M | 100k | 115.15 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $11M | 88k | 129.04 | |
| Kadmon Hldgs | 0.8 | $11M | 2.4M | 4.53 | |
| Kiniksa Pharmaceuticals | 0.7 | $10M | 923k | 11.06 | |
| Medicines Company cmn | 0.7 | $9.3M | 110k | 84.94 | |
| Tg Therapeutics (TGTX) | 0.7 | $9.0M | 811k | 11.10 | |
| Calithera Biosciences | 0.6 | $8.3M | 1.5M | 5.71 | |
| Dermira | 0.6 | $8.3M | 546k | 15.16 | |
| ALEXION PHARMACEUTICALS INC CMN Stock cmn | 0.6 | $8.1M | 75k | 108.17 | |
| Chiasma | 0.6 | $8.1M | 1.6M | 4.96 | |
| ArQule | 0.6 | $7.7M | 388k | 19.96 | |
| Acceleron Pharma | 0.6 | $7.8M | 147k | 53.01 | |
| Iterum Therapeutics | 0.6 | $7.8M | 1.7M | 4.50 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $7.4M | 2.2M | 3.45 | |
| Otonomy | 0.4 | $5.8M | 1.5M | 3.83 | |
| Entasis Therapeutics Holdings Ord | 0.4 | $5.9M | 1.2M | 4.97 | |
| Seattle Genetics | 0.4 | $5.7M | 50k | 114.23 | |
| Forty Seven | 0.4 | $5.5M | 139k | 39.37 | |
| Zymeworks | 0.3 | $4.9M | 108k | 45.45 | |
| Amicus Therapeutics (FOLD) | 0.3 | $4.6M | 475k | 9.74 | |
| Xbiotech (XBIT) | 0.3 | $4.5M | 241k | 18.66 | |
| Foamix Pharmaceuticals | 0.3 | $3.9M | 1.2M | 3.33 | |
| Orchard Therapeutics Plc ads | 0.3 | $3.9M | 283k | 13.75 | |
| Applied Therapeutics (APLT) | 0.3 | $3.7M | 135k | 27.27 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $3.6M | 1.9M | 1.89 | |
| Dicerna Pharmaceuticals | 0.2 | $3.5M | 160k | 22.02 | |
| Kala Pharmaceuticals | 0.2 | $2.5M | 665k | 3.69 | |
| Synlogic | 0.1 | $1.5M | 575k | 2.58 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $1.5M | 50k | 30.62 | |
| Homology Medicines | 0.1 | $1.3M | 64k | 20.68 | |
| Halozyme Therapeutics (HALO) | 0.1 | $1.3M | 73k | 17.74 | |
| Heron Therapeutics (HRTX) | 0.1 | $1.2M | 51k | 23.50 | |
| Rhythm Pharmaceuticals (RYTM) | 0.0 | $489k | 21k | 22.95 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $378k | 143k | 2.65 |
